Evidence map›Paper›PMID 22674508›Full record

ArticleDer Urologe. Ausg. A2012

[Endourological imaging with narrow band imaging].

C Doehn

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Der Urologe. Ausg. A, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

C DoehnUrologikum Lübeck, Kantstraße 15-17, 23566 Lübeck. doehn@urologikum-luebeck.de
Medizinisches Laserzentrum Lübeck (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Narrow band imaging (NBI) is an optical diagnostic procedure which utilizes the narrowing of the wavelength of visible light in the range between 415 and 550 nm. The NBI is mostly used for the diagnostics of inflammation or tumors of the gastrointestinal tract. The first investigations for diagnostics of bladder cancer using NBI date from 2008. Currently data on resection, follow-up and recurrence behavior of bladder cancer are available. In all publications NBI was tested against white light. A randomized study comparing NBI with photodynamic diagnostics has not yet been carried out. In this article current study results on the application of NBI for bladder cancer will be presented.

Indexed as

CystoscopyHumansImage EnhancementLightingUrinary BladderUrinary Bladder Neoplasms

Identifiers

PMID22674508
OpenAlexW140922356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.